Retinal Microvascular Dysfunction Reflects Vascular and Alzheimer's-Related Pathology in Dementia With Lewy Bodies

Qiuling Tong1, William Robert Kwapong2, Xiaoqian Luan3

  • 1Neurology Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Ouhai, China.

Abstract

Insights

Retinal microvascular impairment detected by OCTA is linked to Alzheimer's biomarkers and cognitive decline in Dementia with Lewy bodies (DLB). This non-invasive OCTA imaging offers a new window into DLB's complex neurodegenerative and vascular changes.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Radiology

Background:

  • Dementia with Lewy bodies (DLB) often involves cerebrovascular and Alzheimer's pathology.
  • Accessible in vivo biomarkers for these coexisting conditions in DLB are limited.
  • Retinal microvasculature may serve as a non-invasive indicator of cerebral small vessel changes.

Purpose of the Study:

  • To investigate the relationship between retinal microvascular density and neurodegenerative/vascular markers in DLB.
  • To explore retinal OCTA as a potential biomarker for DLB pathology.
  • To assess associations between retinal findings, plasma biomarkers, and cognitive function.

Main Methods:

  • Cross-sectional study involving 32 DLB patients and 31 controls.
  • Utilized swept-source optical coherence tomography angiography (OCTA) for retinal imaging.
  • Collected plasma biomarkers (amyloid-β, p-tau217) and brain MRI (SVD, WMH) data.

Main Results:

  • DLB patients showed significantly reduced retinal vessel densities in SVC, DVC, and CC compared to controls.
  • Lower retinal vessel densities correlated with higher amyloid burden, p-tau217, SVD, and white matter hyperintensities (WMH).
  • Reduced SVC density was associated with poorer global cognition, partly mediated by WMH.

Conclusions:

  • Retinal microvascular impairment via OCTA is associated with Alzheimer's biomarkers, SVD, and cognitive decline in DLB.
  • OCTA provides a scalable, non-invasive biomarker for DLB.
  • Findings highlight OCTA's potential to reflect combined neurodegenerative and vascular pathology in DLB.